Placebo controlled study of Haloperidol in Schizophrenia.
Main Article Content
Abstract
Objective: The present study aimed to compare the efficacy and safety of haloperidol with placebo in firstepisode schizophrenia.
Place and Time: The sample (n=64) was selected from the outpatient department of the Sir Cows Jee Jehangir
Institute of Psychiatry Hyderabad (CJIP). The selected patients were admitted and randomly grouped (32) to receive haloperidol and placebo (multivitamin). This study was single blinded. Duration of study was three months
from Jan 2011 to March 2011.
Results: Improvements in PANSS, PBRS score from baseline, by haloperidol week-1 2.6 ± 1.63, .67, by placebo
1 results showed < 0.05 siginificant. In week-2 3.14 ± 1.95, .74, by placebo 1.50 ± .71, 50, results showed <0.05
significant. In week-3 2.6 ± 1.63, .67 results showed <0.05 significant. In week-4 3.00 ± 1.58, .71. by placebo 1
results showed <0.05 significant. In week-5 2.50 ± 1.29, .65, by placebo 1 results showed >0.05 insignificant. In
week-6 3.00 ± 1.58,.71, by placebo1 results showed >0.05 insignificant.
Conclusion: In patients with schizophrenia, haloperidol is better than placebo for disease improvement but increases the rates of parkinsonism, akathisia, and acute dystonias substantially.
Key Words: Psychosis, Schizophrenia, Haloperidol, Placebo, Akathesia, Dystonia.
Downloads
Article Details
Journal of Muhammad Medical College (J Muhammad Med Coll) belief that all researches are basically conducted for the benefit of humanity. Research is the product of an investment by society and consequently its fruits should be returned in a transparent fashion to all humankind without any discrimination.
Journal of Muhammad Medical College (JMMC) is an open access journal. All content is freely available immediately upon publication, without charge to the user or their institution. Users are permitted to read, download, copy, distribute, print, search, link to the full text, or otherwise use the content for any lawful purpose, including commercial use, provided the original author(s) and JMMC are properly credited. Articles are published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0):
Authors retain copyright of their work and grant JMMC the right of first publication. No separate copyright transfer or assignment is required.
